A nurse is caring for a client diagnosed with a complete hydatidiform mole who underwent suction curettage 2 days ago. Which nursing intervention is the priority for this client?

Monitoring serial beta-hCG levels is critical to detect malignant transformation to choriocarcinoma, and contraception for 1 year prevents interference with hCG monitoring. Other options are less urgent or premature.

Core Nursing Explanation Key Concept Analysis: This question assesses the priority nursing care for a patient after a Hydatidiform mole (Molar pregnancy). A molar pregnancy is an abnormal proliferation of trophoblastic tissue, resulting in a non-viable pregnancy. The primary concern post-evacuation is the risk of Gestational Trophoblastic Neoplasia (GTN), which includes invasive mole and choriocarcinoma. The cornerstone of management is vigilant monitoring for malignant transformation.

Answer Rationale: Key Point! The priority intervention is Monitoring serial beta-hCG levels. Beta-hCG (human chorionic gonadotropin) is a tumor marker for trophoblastic tissue. After evacuation, levels should steadily decline to normal (Normal Value: < 5 mIU/mL). A plateau or rise in beta-hCG indicates persistent or malignant disease, requiring immediate chemotherapy. Concurrently, Contraception for one year is mandatory to prevent a new pregnancy, which would also produce hCG and confound the monitoring, making it impossible to distinguish a new pregnancy from recurrent disease.

Distractor Analysis:
• Watch out for confusion! Option 1 is incorrect and dangerous. Encouraging conception in 3 months is far too soon and directly contradicts the standard of care, which requires one year of reliable contraception and confirmed normal hCG levels to ensure no residual disease.
• Option 3 is incorrect because it lacks urgency and specificity. While follow-up is important, "routine gynecologic care in 6 months" does not address the critical, short-term need for serial hCG surveillance, which typically occurs every 1-2 weeks until normal for 3 consecutive weeks, then monthly for 6-12 months.
• Option 4, while addressing a valid psychosocial need, is not the physiological priority. Fertility counseling is important but should follow after the immediate threat of GTN is managed and the monitoring plan is established.

Related Concepts: The management of molar pregnancy exemplifies oncology surveillance principles in obstetrics. Understanding the link between beta-hCG as a tumor marker and the need to prevent confounding variables (a new pregnancy) is essential. This also integrates patient education on long-term contraception adherence.
Concept Summary • Pathophysiology: Abnormal fertilization leads to overgrowth of chorionic villi, forming a "mole." It is pre-malignant.
• Primary Risk: Progression to Gestational Trophoblastic Neoplasia (GTN).
• Key Monitoring Tool: Serial quantitative beta-hCG titers.
• Critical Patient Education: Use reliable contraception (e.g., oral contraceptives, IUD) for one full year post-evacuation.
• Goal of Care: Early detection of persistent disease to initiate chemotherapy (e.g., methotrexate) promptly.
Side-by-Side Comparison!

Condition	Key Feature	Post-Evacuation Priority
Complete Hydatidiform Mole	No fetal tissue. 46,XX (all paternal). High hCG.	Serial beta-hCG monitoring for 1 year. Contraception for 1 year.
Incomplete/Partial Mole	Some fetal tissue. Triploid (69,XXY).	Serial beta-hCG monitoring (risk lower than complete mole but still present).
Spontaneous Abortion	Loss of a normal pregnancy.	Physical recovery, emotional support, Rhogam if Rh-negative. No long-term hCG monitoring needed.

Anatomy, Physiology & Pharmacology Points • Beta-hCG: A hormone produced by the syncytiotrophoblast. Its half-life is 24-36 hours. Persistently elevated levels post-mole evacuation signal abnormal trophoblastic proliferation.
• Contraception Choice: Combined oral contraceptives are commonly recommended and do not increase the risk of GTN. They provide reliable pregnancy prevention.
• Chemotherapy Agent: Methotrexate is a first-line treatment for non-metastatic GTN. It is a folic acid antagonist that inhibits DNA synthesis in rapidly dividing cells.
Memory Tips • Acronym: "Mole = Monitor One Year, Love Contraception" (M.O.Y.L.C.) – reminds you of the 1-year monitoring and contraception requirement.
• Think of hCG as a "Tumor Marker": Just like PSA for prostate cancer, you track it to see if the "bad tissue" is gone or growing back.
High-Frequency NCLEX Topics NCLEX loves to test on priority-setting and patient education. This question combines both: the physiological priority (monitoring hCG) and the critical teaching point (contraception). Expect questions that ask "What is the nurse's priority action?" or "Which statement by the client indicates understanding of the teaching?"
Watch Out for Question Variations! • Instead of asking for the priority intervention, it might ask: "The client asks when she can try to get pregnant again. What is the nurse's best response?" (Answer: After one year of normal hCG levels and using contraception).
• It could present lab values: "The client's beta-hCG is 250 mIU/mL 8 weeks post-evacuation. What does this indicate?" (Answer: Persistent disease, requiring further evaluation and likely chemotherapy).

Nursing Clinical Practice Guide Clinical Scenario: You are the nurse on a gynecological unit. M.C., a 32-year-old patient, is being discharged two days after a suction dilation and curettage (D&C) for a complete hydatidiform mole. She is tearful and asks, "When can my husband and I start trying for a baby again?"

Nursing Intervention Strategy:
1. Assessment: Assess her understanding of the diagnosis, her emotional state, and her support system. Check her vital signs and vaginal bleeding (should be light, like a menstrual period).
2. Nursing Diagnosis: Risk for complicated grieving related to pregnancy loss and fear of future fertility. Deficient knowledge regarding follow-up care and contraception.
3. Planning & Implementation:
• Education is Key: Sit with her and explain in clear, empathetic terms: "I know this is a very difficult time. Right now, the most important thing for your health is to make sure all the abnormal tissue is gone. We will need to check your blood every week or two to measure a hormone called hCG. It needs to go down to zero and stay there. If a new pregnancy happens, it will also make hCG, and we won't be able to tell if it's a healthy pregnancy or if the mole is coming back. That's why it's so important to use a very reliable birth control method, like the pill or an IUD, for one full year."
• Provide Concrete Instructions: Give her a printed schedule for beta-hCG blood draws. Provide contact information for the clinic. Discuss contraception options and facilitate a prescription or referral before discharge.
• Address Psychosocial Needs: Acknowledge her loss. Provide resources for counseling or support groups for pregnancy loss. Reassure her that after one year of normal monitoring, her future pregnancy chances are generally excellent, and the risk of recurrence is low (1-2%).
4. Evaluation: Evaluate understanding by asking her to teach back the plan: "Can you tell me in your own words what the next year will look like for your follow-up care?" Ensure she has a confirmed appointment for her first follow-up beta-hCG test.
Nursing Procedure & Medication Flow • Beta-hCG Monitoring Protocol: Typically, levels are drawn every 1-2 weeks until normal for 3 consecutive weeks, then monthly for 6-12 months.
• Contraception Administration: If prescribing oral contraceptives, educate on consistent daily use. For an IUD, coordinate insertion post-evacuation once infection is ruled out.
• Warning Signs to Teach: Report immediately: heavy vaginal bleeding, severe pelvic pain, shortness of breath (risk of pulmonary embolism from trophoblastic tissue), or symptoms of hyperthyroidism (rare, due to high hCG acting like TSH).
A Word from Your Senior Nurse "Managing a molar pregnancy is a unique blend of oncology nursing and sensitive obstetrical care. You're not just caring for a surgical patient; you're guiding a woman through a significant loss while vigilantly guarding against cancer. That teaching moment about contraception isn't just a routine instruction—it's a critical, life-preserving intervention. In clinical practice, your empathetic yet firm reinforcement of this plan can be the difference between a full recovery and a missed diagnosis. On the NCLEX, they test this because it's a non-negotiable standard of care. Remember: Monitor the marker, prevent the pregnancy, protect the patient."